Cost-effectiveness of treatment optimisation with biomarkers for immunotherapy in solid tumours: a systematic review protocol
Introduction The combination of biomarkers and drugs is the subject of growing interest both from regulators, physicians and Smart Mirror LCD Display companies.This study protocol of a systematic review is aimed to describe available literature evidences about the cost-effectiveness, cost-utility or net-monetary benefit of the use of biomarkers in